Skip to main content

Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots

Canada's Covid shot settlement is a sign of hope for investors after Novavax raised doubts about its ability to stay in business earlier this year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.